InvestorsHub Logo
Followers 2
Posts 429
Boards Moderated 0
Alias Born 07/13/2016

Re: buckysherm post# 16795

Tuesday, 08/22/2017 12:09:24 PM

Tuesday, August 22, 2017 12:09:24 PM

Post# of 232325
A label expansion typically requires some additional testing, even if not a full blown phase III. That takes time and money. My guess is the company focuses on mono rather than trying for a label expansion on combo. IF the goal is to sell the company to Gilead or Viiv, mono is the way to go as that represents the biggest threat to their current HIV franchises.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News